Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 43 Neoplasms 24 Motor Activity 12 Pain, Postoperative 9 Colorectal Neoplasms 9 Stomach Neoplasms 8 Lung Neoplasms 8 Fatigue 7 Anxiety Disorders 6 Pain 5 Carcinoma, Hepatocellular 5 Rectal Neoplasms 4 Polycystic Ovary Syndrome 4 Leukemia, Myeloid, Acute 4 Depression 4 Colonic Neoplasms 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Stomatitis 3 Squamous Cell Carcinoma of Head and Neck 3 Sleep Initiation and Maintenance Disorders 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Malnutrition 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Agnosia 3 Vomiting 2 Urinary Incontinence 2

Interventions

Rituximab 9 Valganciclovir 6 Etoposide 4 Doxorubicin 4 Valacyclovir 3 Gemcitabine 3 Dexamethasone 3 Cyclophosphamide 3 Cisplatin 3 spartalizumab 2 pembrolizumab 2 pegaspargase 2 Zidovudine 2 Vincristine 2 Radiotherapy, Intensity-Modulated 2 Prednisone 2 Methylprednisolone 2 Methotrexate 2 Matrix-M 2 Leucovorin 2 Lenalidomide 2 Cell Count 2 Carboplatin 2 Blood Specimen Collection 2 Acyclovir 2 valomaciclovir 1 toripalimab 1 threonic acid 1 ruxolitinib 1 pomalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Epstein-Barr Virus Infections × Control Groups × Clear all

NCT04989491 2024-08-19

REPLY

University Hospital, Strasbourg, France

Phase 4 Recruiting

Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡